The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
GFAP promoter elements required for region‐specific and astrocyte‐specific expression
Abstract
Glial fibrillary acidic protein (GFAP) is the major intermediate filament protein in astrocytes, one of the most abundant cell types in the vertebrate central nervous system (CNS). Transcriptional regulation of GFAP is of interest because of its astrocyte‐specificity and its upregulation during development and CNS injury. A 2.2 kb human GFAP promoter, gfa2, has been found to express in astrocytes throughout the CNS. In contrast, we recently found that the 448 bp gfa28 promoter expresses in only restricted CNS regions, and is active in neurons as well as astrocytes. In the present study we have used transgenic mice to investigate which DNA regions deleted from gfa2 in the formation of gfa28 are responsible for these differences. We have found that a 55 bp segment spanning bp −1488 to −1434 with respect to the RNA start site contains region‐specific elements and that a 45 bp sequence spanning bp −1443 to −1399 is required for silencing expression in neurons. These data also further confirm the heterogeneity of astrocytes and neurons in the activation and repression of the GFAP gene, respectively. These studies also generated a novel 681 bp GFAP promoter, gfaABC 1 D, that has essentially the same expression pattern as the 2210 bp gfa2 promoter, and about twofold greater activity, recommending it for gene targeting applications in which size matters. In addition, a 681 bp gfaABC 1(mC 1.1)D variant was generated that could limit expression of transgenes to astrocytes in the dorsal and caudal cortex, hippocampus and caudal vermis of the cerebellum. © 2008 Wiley‐Liss, Inc.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Neuronal dysfunction of striatal neurons precedes their degeneration, and the dopamine receptor D2 (DRD2) MSNs of the indirect pathway are the first affected in HD models and patients.
“Neuronal dysfunction of striatal neurons precedes their degeneration, and the dopamine receptor D2 (DRD2) MSNs of the indirect pathway are the first affected in HD models and patients 33,34,35,36 .”
From SREBP2 gene therapy targeting striatal astrocytes ameliorates Huntington’s disease phenotypes (2021) · cites this paper as [36]
Citations
Cites
An acidic protein isolated from fibrous astrocytes
Eng, L. F., Vanderhaeghen, J. J., Bignami, A., & Gerstl, B. (1971) · Brain Research · doi:10.1016/0006-8993(71)90668-8 · Cited by 1,230
Flagged first, then by citations
Research works printed but not linked: 36
- 10.1093/nar/19.9.2499 · DOI
- 10.1016/0014-5793(92)80687-C · DOI
- 10.1002/glia.20242 · DOI
- Besnard F, 1991, Multiple interacting sites regulate astrocyte‐specific transcription of the human gene for glial fibrillary acidic protein, J Biol Chem, 266, 18877, 10.1016/S0021-9258(18)55145-0 · DOI
- 10.1016/0006-8993(72)90398-8 · DOI
- 10.1126/science.278.5337.477 · DOI
- 10.1111/j.1750-3639.1994.tb00840.x · DOI
- 10.1523/JNEUROSCI.14-03-01030.1994 · DOI
- 10.1016/j.neuroscience.2004.11.008 · DOI
- 10.1002/jnr.20776 · DOI
- 10.1093/nar/11.5.1475 · DOI
- 10.1101/gad.2.12a.1647 · DOI
- 10.1111/j.1750-3639.1994.tb00838.x · DOI · Paper page
- 10.1093/nar/27.1.318 · DOI
- 10.1016/S0021-9258(18)49981-4 · DOI
- 10.1046/j.1471-4159.1997.68041413.x · DOI
- 10.1016/j.devbrainres.2005.07.012 · DOI
- 10.1167/iovs.02-1265 · DOI
- 10.1002/glia.20320 · DOI
- 10.1038/sj.onc.1204593 · DOI
- 10.1128/MCB.11.10.5229 · DOI
- Martin A, 2003, Glial reactivity in ciliary neurotrophic factor‐deficient mice after optic nerve lesion, J Neurosci, 23, 5416, 10.1523/JNEUROSCI.23-13-05416.2003 · DOI
- MasoodK BesnardF SuY BrennerM.1993.Analysis of a segment of the human glial fibrillary acidic protein gene that directs astrocyte‐specific transcription.61:160–166. · DOI
- 10.1111/j.1471-4159.2006.03810.x · DOI
- 10.1016/S0896-6273(02)01026-7 · DOI
- 10.1242/dev.117.1.191 · DOI
- 10.1023/A:1008995730285 · DOI
- 10.1006/dbio.1999.9278 · DOI
- 10.1523/JNEUROSCI.2662-05.2005 · DOI
- 10.1016/j.tins.2003.08.006 · DOI
- 10.1023/A:1015372322419 · DOI
- Schmidt‐Ullrich R, 1996, NF‐κB activity in transgenic mice: Developmental regulation and tissue specificity, Development, 22, 2117, 10.1242/dev.122.7.2117 · DOI
- 10.1002/jnr.21001 · DOI
- 10.1007/s11064-004-6881-1 · DOI · Paper page
- 10.1074/jbc.271.38.23520 · DOI
- Zhou H, 2001, Atypical mouse cerebellar development is caused by ectopic expression of the forkhead box transcription factor HNF‐3β, Gene Expr, 9, 217, 10.3727/000000001783992597 · DOI
Cited by
Sorted by citations
Middeldorp, J., & Hol, E. M. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.01.005 · Cited by 1,080
In vivo evidence for a lactate gradient from astrocytes to neurons
Mächler, P., Wyss, M. T., Elsayed, M., Stobart, J., Gutierrez, R., von Faber-Castell, A., Kaelin, V., Zuend, M., San Martín, A., Romero-Gómez, I., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.10.010 · Cited by 571
Vargas, M. R., Johnson, D. A., Sirkis, D. W., Messing, A., & Johnson, J. A. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4099-08.2008 · Cited by 479
Self-citationGut-licensed IFNγ+ NK cells drive LAMP1+TRAIL+ anti-inflammatory astrocytes
Sanmarco, L. M., Wheeler, M. A., Gutiérrez-Vázquez, C., Polonio, C. M., Linnerbauer, M., Pinho-Ribeiro, F. A., Li, Z., Giovannoni, F., Batterman, K. V., Scalisi, G., et al. (2021) · Nature · doi:10.1038/s41586-020-03116-4 · Cited by 331
Revisiting astrocyte to neuron conversion with lineage tracing in vivo
Wang, L.-L., Serrano, C., Zhong, X., Ma, S., Zou, Y., & Zhang, C.-L. (2021) · Cell · doi:10.1016/j.cell.2021.09.005 · Cited by 329
Gene therapy for neurological disorders: progress and prospects
Deverman, B. E., Ravina, B. M., Bankiewicz, K. S., Paul, S. M., & Sah, D. W. Y. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.110 · Cited by 306
Improved tools to study astrocytes
Yu, X., Nagai, J., & Khakh, B. S. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-0264-8 · Cited by 298
Ceyzériat, K., Ben Haim, L., Denizot, A., Pommier, D., Matos, M., Guillemaud, O., Palomares, M.-A., Abjean, L., Petit, F., Gipchtein, P., et al. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0606-1 · Cited by 256
A sensitive GRAB sensor for detecting extracellular ATP in vitro and in vivo
Wu, Z., He, K., Chen, Y., Li, H., Pan, S., Li, B., Liu, T., Xi, F., Deng, F., Wang, H., et al. (2022) · Neuron · doi:10.1016/j.neuron.2021.11.027 · Cited by 204
Clasadonte, J., Scemes, E., Wang, Z., Boison, D., & Haydon, P. G. (2017) · Neuron · doi:10.1016/j.neuron.2017.08.022 · Cited by 200
Viral Strategies for Targeting the Central and Peripheral Nervous Systems
Bedbrook, C. N., Deverman, B. E., & Gradinaru, V. (2018) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-080317-062048 · Cited by 168
Rapid evolution of blood-brain-barrier-penetrating AAV capsids by RNA-driven biopanning
Nonnenmacher, M., Wang, W., Child, M. A., Ren, X.-Q., Huang, C., Ren, A. Z., Tocci, J., Chen, Q., Bittner, K., Tyson, K., et al. (2021) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2020.12.006 · Cited by 168
Next-generation AAV vectors—Do not judge a virus (only) by its cover
Domenger, C., & Grimm, D. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz148 · Cited by 147
Glial Dysfunction in the Mouse Habenula Causes Depressive-Like Behaviors and Sleep Disturbance
Cui, W., Mizukami, H., Yanagisawa, M., Aida, T., Nomura, M., Isomura, Y., Takayanagi, R., Ozawa, K., Tanaka, K., & Aizawa, H. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1465-14.2014 · Cited by 139
Ojala, D. S., Sun, S., Santiago-Ortiz, J. L., Shapiro, M. G., Romero, P. A., & Schaffer, D. V. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2017.09.006 · Cited by 97
Methods for Gene Transfer to the Central Nervous System
Kantor, B., Bailey, R. M., Wimberly, K., Kalburgi, S. N., & Gray, S. J. (2014) · Advances in Genetics · doi:10.1016/b978-0-12-800149-3.00003-2 · Cited by 109
A GATA4-regulated tumor suppressor network represses formation of malignant human astrocytomas
Agnihotri, S., Wolf, A., Munoz, D. M., Smith, C. J., Gajadhar, A., Restrepo, A., Clarke, I. D., Fuller, G. N., Kesari, S., Dirks, P. B., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20102099 · Cited by 92
Chen, W., Zheng, Q., Huang, Q., Ma, S., & Li, M. (2022) · eLife · doi:10.7554/elife.75636 · Cited by 89
Lineage tracing of direct astrocyte-to-neuron conversion in the mouse cortex
Wang, Q., Li, W., Lei, W., Chen, G., Xiang, Z., Xu, L., & Liu, M. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.295925 · Cited by 53
Merienne, N., Douce, J. L., Faivre, E., Déglon, N., & Bonvento, G. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00106 · Cited by 58
Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery
Joshi, C. R., Labhasetwar, V., & Ghorpade, A. (2017) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-016-9724-3 · Cited by 55
SREBP2 gene therapy targeting striatal astrocytes ameliorates Huntington’s disease phenotypes
Birolini, G., Verlengia, G., Talpo, F., Maniezzi, C., Zentilin, L., Giacca, M., Conforti, P., Cordiglieri, C., Caccia, C., Leoni, V., et al. (2021) · Brain · doi:10.1093/brain/awab186 · Cited by 48
Hypoxia-regulated retinal glial cell-specific promoter for potential gene therapy in disease
Prentice, H. M., Biswal, M. R., Dorey, C. K., & Blanks, J. C. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6835 · Cited by 35
Nuclear SphK2/S1P signaling is a key regulator of ApoE production and Aβ uptake in astrocytes
Komai, M., Noda, Y., Ikeda, A., Kaneshiro, N., Kamikubo, Y., Sakurai, T., Uehara, T., & Takasugi, N. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100510 · Cited by 13
Metadata
- Authors
- Lee, Y., Messing, A., Su, M., & Brenner, M.
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2008-01-31
- Volume
- 56
- Issue
- 5
- Pages
- 481-493
- ISSN
- 0894-1491
- 1098-1136
- Cited by
- 424
- References
- 1
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review